Cardiovascular risk evaluation in patients with hypertension under pharmacotherapeutic follow-up in primary health care

Authors

  • PAULO YURI MILEN FIRMINO
  • BRUNA CRISTINA CARDOSO MARTINS
  • SARAH DE CARVALHO FREITAS ALVES
  • TAINÁ OSTERNO VASCONCELOS
  • LÍVIA FALCÃO LIMA
  • BRUNA ESMERALDO OLIVEIRA
  • VANESSA MARIA DE SOUZA FERNANDES VIEIRA
  • ÂNGELA MARIA DE SOUZA PONCIANO
  • LUZIA IZABEL MESQUITA MOREIRA DA SILVA
  • MARTA MARIA DE FRANÇA FONTELES

Keywords:

Atenção Farmacêutica; Risco Cardiovascular; Hipertensão Arterial Sistêmica.

Abstract

Objective: This longitudinal follow-up study, , aimed to investigate the influence of a Pharmaceutical Care service on the cardiovascular risk rate of patients with hypertension attending a Primary Care Unit located in Ceará.

Methods: A pharmacotherapeutic follow-up was carried out for 6 months according to the Dáder Method. At the beginning and end of the follow-up, the patients’ laboratory investigations and blood pressure results were registered. These indicators are necessary to calculate the risk rate from the Framingham Scale. The results were analyzed with Sigma Plot software using the Student t and Wilcoxon tests, set at a significance level of 5%.

Results: Significant differences were observed on the mean values of cardiovascular risk rate, reducing from 13,4% to 9,5% at the end of the study, and systolic blood pressure, initial value of 146,1mmHg and final value of 128,7mmHg, representing reductions of 29% and 11,9% of the initial value, respectively. The reductions tended to be proportional to the length of the follow-up.

Conclusion: Our findings suggest that the pharmacotherapeutic follow-up can effectively reduce cardiovascular risk rate and systolic blood pressure. These findings emphasize the importance of the practice of Pharmaceutical Care in patients with hypertension as a good strategy to improve their current health status and the prevention of future complications.

Descriptors: Pharmaceutical Care; Cardiovascular Risk; Arterial Systemic Hypertension.

Downloads

Download data is not yet available.

Published

2019-03-11

How to Cite

1.
FIRMINO PYM, MARTINS BCC, ALVES SDCF, VASCONCELOS TO, LIMA LF, OLIVEIRA BE, VIEIRA VMDSF, PONCIANO ÂNGELA MDS, SILVA LIMMD, FONTELES MMDF. Cardiovascular risk evaluation in patients with hypertension under pharmacotherapeutic follow-up in primary health care. Rev Bras Farm Hosp Serv Saude [Internet]. 2019Mar.11 [cited 2024Jul.17];3(2). Available from: https://www.rbfhss.org.br/sbrafh/article/view/129

Issue

Section

ARTIGOS PUBLICADOS

Most read articles by the same author(s)